Ichor Medical Systems Competitors and Similar CompaniesClear all

Ichor Medical Systems's competitors and similar companies include AnGes, Ionis Pharmaceuticals, CRISPR Therapeutics and Intellia Therapeutics.

	Ichor Medical Systems Ichor Medical Systems is a biotech company developing products based on the in vivo application of electroporation.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
Founding Date	Founding Date 1994	Founding Date 1999	Founding Date 1989	Founding Date 2013	Founding Date 2014
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech
Locations	Locations San Diego, US HQ	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations Carlsbad, US HQ Vancouver, CA Stuttgart, DE Dublin, IE Dublin, IE Lisboa, PT London, GB see more	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US	Locations Cambridge, US HQ
Employees	Employees 8	Employees 5562% decrease	Employees 1,40231% increase	Employees 393	Employees 40323% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 78.3 m	Valuation ($) 6.3 b	Valuation ($) 4.2 b	Valuation ($) 1.7 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) $943.7m (FY, 2025)	Revenue (est.) $3.5m (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)	Cost of goods $15.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit ¥374.2m (FY, 2025)	Gross profit $927.8m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (¥5.1b) (FY, 2025)	Net income ($381.4m) (FY, 2025)	Net income ($581.6m) (FY, 2025)	Net income ($412.7m) (FY, 2025)